• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SEASPINE INC. DYNABLAST PASTE 1CC BONE GRAFTING MATERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SEASPINE INC. DYNABLAST PASTE 1CC BONE GRAFTING MATERIAL Back to Search Results
Model Number 10-210-1060
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Itching Sensation (1943)
Event Date 01/01/2016
Event Type  Injury  
Manufacturer Narrative
A device history record (dhr) review was conducted for lot 102268, and it was concluded that the products were inspected and accepted for use by the quality control department on 09/27/10 and met all specified parameters of the receiving inspection report (rir) with no associated nonconformances. Donor records were also reviewed, and product was approved on 09/23/09. The device was unable to be evaluated as the paste remained implanted. However, a medical review and assessment of the event was completed and determined that the reaction was a result of the restorative metals used in the procedure and that the fibrous strands were likely not related to the dynablast paste, as the material could not be identified in the pathology reports and dynablast paste is not comprised of fibrous strands. The reported allegation of post-operative reaction due to dynablast paste was not confirmed. A root cause of the fibrous strands was undetermined, and the reaction was determined to be the result of the restorative metals. Additionally, it was found during the investigation that the implants were placed 3 months after grafting with dynablast. Per the dfu, implant placement should begin approximately 6 months after grafting with dynablast. Review of labeling notes: warnings and precautions: sites grafted with dynablast should be allowed to heal approximately 6 months prior to implant placement.
 
Event Description
In (b)(6) 2011, the patient received dynablast paste in location #30. In (b)(6) 2011 she received an implant at the site and restoration was completed in (b)(6) 2011. In 2014, the patient began pulling fibrous strands out of the site. A pathology report was performed on (b)(6) 2014, and the results were inconclusive. In 2015, the patient began to experience inflammation and itching around the site and she continued to pull out fibrous strands. An additional pathology report was performed on (b)(6) 2015 which concluded that she had type iv hypersensitivity to the metals used in the restoration and all restorative components were removed. However, the patient continued to express signs of allergic reaction and fibrous strands. Patient was concerned that the issue may have been with the bone graft material. At the time of contact, no additional event information was available.
 
Manufacturer Narrative
This supplemental is to retract report 2090010-2019-00002, submitted in error, as keystone dental is responsible for mdr reporting requirements per quality agreement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameDYNABLAST PASTE 1CC
Type of DeviceBONE GRAFTING MATERIAL
Manufacturer (Section D)
SEASPINE INC.
2 goodyear
irvine CA 92618
Manufacturer Contact
stephanie chavez
5770 armada drive
carlsbad, CA 92008
7602165109
MDR Report Key8534704
MDR Text Key142613419
Report Number2090010-2019-00002
Device Sequence Number1
Product Code NUN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K060332
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation
Type of Report Initial,Followup
Report Date 04/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model Number10-210-1060
Device Lot Number102268
Was Device Available for Evaluation? No
Is the Reporter a Health Professional?
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received03/22/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 04/22/2019 Patient Sequence Number: 1
Treatment
DENTAL IMPLANTS
-
-